Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal
Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...
HotCopper on MSN11h
Avecho clocks $4.7M payment from pharma giant Sandoz for CBD capsule licence
Avecho (ASX:AVE) has received a US$3 million (A$4.7 million) payment from pharma heavyweight Sandoz in exchange for the ...
Small Caps14h
Avecho Biotechnology advances CBD insomnia trial with Sandoz licensing deal and funding
Avecho Biotechnology (ASX: AVE) has received a maiden payment of approximately $4.7 million (US$3m) from international ...
Uni-Bio Science Group Limited Announces 2024 Annual Results Media Outreach Newswire APAC
HONG KONG SAR - EQS Newswire - 27 March 2025 - A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (Uni-Bio Scienc ...